dc.contributor.author | OYAN ULUÇ, Başak | |
dc.contributor.author | Ozkan, Berker | |
dc.contributor.author | Yenigun, Mustafa B. | |
dc.contributor.author | Yilmazbayhan, Dilek | |
dc.contributor.author | Toker, Alper | |
dc.contributor.author | Ferhatoglu, Ferhat | |
dc.contributor.author | Yasar, Arzu | |
dc.contributor.author | SAK, SERPİL | |
dc.contributor.author | Tanju, Serhan | |
dc.contributor.author | Dilege, Sukru | |
dc.contributor.author | Erus, Suat | |
dc.contributor.author | Bulutay, Pinar | |
dc.contributor.author | Firat, Pinar | |
dc.contributor.author | Mandel, Nil Molinas | |
dc.contributor.author | Kilickap, Sadettin | |
dc.contributor.author | Onder, Sevgen | |
dc.contributor.author | DİKMEN, ERKAN | |
dc.contributor.author | Alan, Ozkan | |
dc.contributor.author | Yumuk, Perran F. | |
dc.contributor.author | BOZKURTLAR, EMİNE | |
dc.contributor.author | LAÇİN, TUNÇ | |
dc.contributor.author | YILDIZELİ, BEDRETTİN | |
dc.contributor.author | Ozturk, Akin | |
dc.contributor.author | Ak, Naziye | |
dc.contributor.author | Eralp, Yesim | |
dc.contributor.author | Urer, Nur | |
dc.contributor.author | Aydiner, Adnan | |
dc.contributor.author | DEMİRKAZIK, AHMET | |
dc.contributor.author | Kocaturk, Celalettin | |
dc.contributor.author | Karapinar, Kemal | |
dc.date.accessioned | 2021-12-10T12:23:22Z | |
dc.date.available | 2021-12-10T12:23:22Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Ak N., Ozkan B., Yenigun M. B. , Yilmazbayhan D., Toker A., Ferhatoglu F., Yasar A., SAK S., Tanju S., Dilege S., et al., "The role of adjuvant chemotherapy in resected stage I non - small cell lung cancer: A Turkish Oncology Group Study", JOURNAL OF BUON, cilt.26, sa.3, ss.819-829, 2021 | |
dc.identifier.issn | 1107-0625 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_b98164be-2020-420d-825e-5a058e57ee14 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/173788 | |
dc.description.abstract | Purpose: The benefit of adjuvant chemotherapy for tumors smaller than 4 cm is not clear. We aimed to evaluate the prognostic impact of adjuvant platin-based chemotherapy in high-risk stage I patients with non-small cell lung cancer (NSCLC). | |
dc.language.iso | eng | |
dc.subject | Onkoloji | |
dc.subject | Oncology | |
dc.subject | Health Sciences | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.title | The role of adjuvant chemotherapy in resected stage I non - small cell lung cancer: A Turkish Oncology Group Study | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF BUON | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 26 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 819 | |
dc.identifier.endpage | 829 | |
dc.contributor.firstauthorID | 2693290 | |